Kyto Biopharma, Inc., a biopharmaceutical company, acquires and develops minimally toxic and non-immunosuppressive proprietary drugs for the treatment of cancer, arthritis, and other proliferate and autoimmune diseases. History The company was founded in 1999. It was incorporated as a Florida corporation in 1999. The company was formerly known as B Twelve, Inc. and changed its name to Kyto Biopharma, Inc. in 2002.
kyto biopharma inc (KBPH:OTC US)
500 Australian Avenue South
West Palm Beach, FL 33401
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for KBPH.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact KYTO BIOPHARMA INC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.